KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Shares Issued (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Shares Issued for 17 consecutive years, with $3.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued changed 0.0% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.8 million, a 17.71% decrease, with the full-year FY2025 number at $15.8 million, down 17.71% from a year prior.
  • Shares Issued was $3.9 million for Q4 2025 at Bio-Rad Laboratories, up from $3.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $6.2 million in Q4 2021 to a low of -$15.5 million in Q3 2021.
  • A 5-year average of $3.5 million and a median of $4.3 million in 2023 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 226.85% in 2021; the steepest drop was 1531.48% in 2021.
  • Bio-Rad Laboratories' Shares Issued stood at $6.2 million in 2021, then dropped by 29.0% to $4.4 million in 2022, then dropped by 1.14% to $4.3 million in 2023, then decreased by 9.97% to $3.9 million in 2024, then changed by 0.0% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Shares Issued are $3.9 million (Q4 2025), $3.4 million (Q3 2025), and $4.2 million (Q2 2025).